The Administrative Core supports the Duke Cancer Institute (DCI) Executive Director, senior leaders, program leaders, and members with articulating the vision for the DCI, developing the objectives that support the vision, and seeking the input from a broad range of DCI members to collaboratively set priorities and create actionable plans. The Administrative Core does this through developing and facilitating the processes that coordinate and integrate the activities of research programs, shared resources, clinical trials operations, and institutional administrative functions to form a cohesive center. This includes: developing and managing detailed, coordinated, recruitment and membership processes; providing oversight and management of shared resources through senior administrative support of the Shared Resource Oversight Committee; developing policies and procedures for managing space for faculty under the authority of the Executive Director; providing fiscal management of the DCI including overseeing both School of Medicine and Duke University Health System business functions, budgeting, accounting, and expense monitoring; managing the administrative mechanisms supporting developmental funds distribution; overseeing activities relevant to the CCSG grant application process; and engaging in organizational performance monitoring. In addition, while communication is paramount to the success of large, complex, multidisciplinary programs and activities, it is difficult to assure. Accordingly, the Administrative Core develops and implements mechanisms to communicate with internal and external constituents and stakeholders to assure the goals of the DCI are achieved. Senior leaders work together with centralized DCI senior administrative staff to perform these functions and create a cohesive leadership structure through: collectively engaging in planning activities facilitated by the Administrative Core; collaboratively setting priorities and making decisions through key committees; assuring key committees are cross-pollinated with senior leaders to facilitate broad based strategic and operational communications; co- leading focused initiatives when they span multiple areas of the DCI; utilizing common data, documentation, and information sources electronically supported and distributed regularly by the DCI senior administrative team; and leading and participating in multiple transdisciplinary seminars, symposia, and retreats to facilitate new, productive interactions that accelerate translation of discoveries from bench to bedside to communities and improve the cancer profile of the catchment area.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-45
Application #
9620025
Study Section
Subcommittee I - Career Development (NCI)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
45
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Feng, Yun; Wang, Yanru; Liu, Hongliang et al. (2018) Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol Carcinog 57:216-224
Naqvi, Ibtehaj; Gunaratne, Ruwan; McDade, Jessica E et al. (2018) Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. Mol Ther 26:1020-1031
Wen, Juyi; Liu, Hongliang; Wang, Lili et al. (2018) Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy. J Thorac Oncol 13:660-675
Li, Bo; Wang, Yanru; Xu, Yinghui et al. (2018) Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer 142:2303-2312
Gearhart-Serna, Larisa M; Jayasundara, Nishad; Tacam Jr, Moises et al. (2018) Assessing Cancer Risk Associated with Aquatic Polycyclic Aromatic Hydrocarbon Pollution Reveals Dietary Routes of Exposure and Vulnerable Populations. J Environ Public Health 2018:5610462
Bakthavatsalam, Subha; Sleeper, Mark L; Dharani, Azim et al. (2018) Leveraging ?-Glutamyl Transferase To Direct Cytotoxicity of Copper Dithiocarbamates against Prostate Cancer Cells. Angew Chem Int Ed Engl 57:12780-12784
Dai, Ziwei; Mentch, Samantha J; Gao, Xia et al. (2018) Methionine metabolism influences genomic architecture and gene expression through H3K4me3 peak width. Nat Commun 9:1955
Powell Gray, Bethany; Kelly, Linsley; Ahrens, Douglas P et al. (2018) Tunable cytotoxic aptamer-drug conjugates for the treatment of prostate cancer. Proc Natl Acad Sci U S A 115:4761-4766
Abdi, Khadar; Lai, Chun-Hsiang; Paez-Gonzalez, Patricia et al. (2018) Uncovering inherent cellular plasticity of multiciliated ependyma leading to ventricular wall transformation and hydrocephalus. Nat Commun 9:1655
Hudson, Kathryn E; Rizzieri, David; Thomas, Samantha M et al. (2018) Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study. Br J Haematol :

Showing the most recent 10 out of 513 publications